Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-04-15
著者
-
HEIKE Yuji
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Tobinai Kensei
東海大学 医学部
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
Onishi Yasushi
Department Of Biostatistics School Of Public Health University Of Tokyo
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
Heike Yuji
国立がんセンター中央病院 血液内科グループ
-
Heike Yuji
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Takamatsu Y
Department Of Hematology Imamura Bun-in Hospital
-
Takaue Yoichi
徳島大学 小児
-
Togitani Kazuto
Hematology Division National Cancer Center Hospital
-
Tanosaki R
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Tanosaki Ryuji
国立がんセンター中央病院 造血幹細胞移植グループ
-
Tanosaki Ryuji
Hematopoietic Stem Cell Transplantation Unit National Cancer Center Hospital
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Onishi Yasushi
東北大学 血液･免疫病学分野
-
Onishi Yasushi
Tohoku Univ. Graduate School Of Medicine Sendai Jpn
-
Kusumoto Shigeru
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Kim Sung-won
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tanimoto Kazuki
国立がんセンター中央病院
-
ONISHI Yasushi
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
MORI Shin-ichiro
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
SUGIMOTO Kyoko
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
AKAHANE Daigo
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
MORITA HOSHI
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
KIM Sung-Won
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
FUKUDA Takahiro
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
HEIKE Yuji
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
TANOSAKI Ryuji
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
TOBINAI Kensei
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
TAKAUE Yoichi
Division of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
-
Shimoyama M
Department Of Hematology Anjo Kosei Hospital
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
Kuroishi Tetsuo
愛知県がんセンター研究所
-
Ryuji Tamura
Department Of Materials Science And Technology Science University Of Tokyo
-
Shamoto M
Fujita Health Univ. Toyoake Jpn
-
Takaue Y
National Cancer Center Hospital Tokyo Jpn
-
Takaue Yoichi
University Of Tokushima
-
Takaue Yoichi
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Takaue Yoichi
Hematopoietic Stem Cell Transplant/immunotherapy Division National Cancer Center Hospital
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Takatsuki K
Kumamoto Univ. School Of Medicine Kumamoto Jpn
-
Kim Sung-won
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Takaue Yoichi
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Mori Shin‐ichiro
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Fukuda Takahiro
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Tobinai Kensei
National Cancer Center Hospital
-
Tobinai Kensei
Department Of Pharmacotherapy National Cancer Institute
-
Shirai Masato
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Takamatsu Yasushi
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Yamashita Takeshi
Department Of Internal Medicine Ntt West Kanazawa Hospital
-
Morita Hoshi
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Akahane Daigo
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Tanosaki Ryuji
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Sugimoto Kyoko
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tanimoto K
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Mori Shigeo
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Seto Masao
Department Of Hematology/oncology Nagoya National Hospital
-
Moritaka S
Department Of Surgery Ii Nagoya City University Medical School
-
Oki Yasuhiro
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Heike Yuji
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Mori Shin-ichiro
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Miura Shigeto
Department Of Surgery Aichi Cancer Center
-
Yoda Takashi
Department Of Pediatrics St. Marianna University School Of Medicine
-
Suzuki Masumi
Department Of Thoracic Surgery Aichi Cancer Center Hospital
-
FUKUDA Takahiro
Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Accumulation of common polymorphisms is associated with development of hypertension : a 12-year follow-up from the Ohasama study
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Quantification of molecules in ^1H-NMR metabolomics with formate as a concentration standard
- Standardized Prevalence Ratios for Chronic Hepatitis C Virus Infection Among Adult Japanese Hemodialysis Patients
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Dietary Risk Factors for Colon and Rectal Cancers : A Comparative Case-Control Study
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Plasma B-Type Natriuretic Peptide Level and Cardiovascular Events in Chronic Kidney Disease in a Community-Based Population
- Factors Influencing Participation Rate in a Baseline Survey of a Genetic Cohort in Japan
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Iron Intake and Associated Factors in General Japanese Population : NIPPON DATA80, NIPPON DATA90 and National Nutrition Monitoring
- 1P345 NMRメタボロミクスの医療への応用 : 透析患者血漿と廃液の解析(その他,第48回日本生物物理学会年会)
- CHANGES IN ACTIVITIES OF DAILY LIVING,PHYSICAL FITNESS, AND DEPRESSIVE SYMPTOMS AFTER SIX-MONTH PERIODIC WELL-ROUNDED EXERCISE PROGRAMS FOR OLDER ADULTS LIVING IN NURSING HOMES OR SPECIAL NURSING FACILITIES
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan
- Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis : A retrospective study
- Interaction of the Effects of Alcohol Drinking and Polymorphisms in Alcohol-Metabolizing Enzymes on the Risk of Female Breast Cancer in Japan
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Broken Sperm, Cytoplasmic Droplets and Reduced Sperm Motility Are Principal Markers of Decreased Sperm Quality Due to Organophosphorus Pesticides in Rats
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Induction of antitimor cytotoxic activity using CD34^+ cord blood cell-derived and irradiated tumor cell-primed dendritic cells
- Effects of interleukin-11 on carboplatin-induced thrombocytopenia in rats and in combination with stem cell factor
- Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Aggressive CD5-positive diffuse large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia
- Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers
- Effects of a 12-Month Multicomponent Exercise Program on Physical Performance, Daily Physical Activity, and Quality of Life in Very Elderly People With Minor Disabilities : An Intervention Study
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Early Detection of Plasma Cytomegalovirus DNA by Real-Time PCR after Allogeneic Hematopoietic Stem Cell Transplantation
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Rationale, Design, and Profiles of the New Integrated Suburban Seniority Investigation (NISSIN) Project : A Study of an Age-Specific, Community-Based Cohort of Japanese Elderly
- TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation
- A Human T-Cell Lymphotropic Virus Type-I Carrier with Chronic Renal Failure, Aplastic Anemia, Myelopathy, Uveitis, Sjogren's Syndrome and Panniculitis
- Paroxysmal Nocturnal Hemoglobinuria
- Markedly high plasma erythropoietin and granulocyte-colony stimulating factor levels in patients with paroxysmal nocturnal hemoglobinuria
- Cyclosporin-responsive pancytopenia and HLA class II alleles of a patient with paroxysmal nocturnal hemoglobinuria
- T-lymphoblastic lymphoma/leukemia cells nagative for CD52 and CD59
- Migration to an inflammatory site in vivo of paroxysmal nocturnal hemoglobinuria lymphocytes
- Induction of the C/EBPβ Gene by Dexamethasone and Glucagon in Primary-Cultured Rat Hepatocytes^1
- Serum amino acid disturbance in multiple myeloma with hyperammonemia
- Hyperdiploid myeloma cell as an indicator of poor prognosis and drug refractoriness
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Significant association of RUNX3 T/A polymorphism at intron 3 (rs760805) with the risk of gastric atrophy in Helicobacter pylori seropositive Japanese
- Clinical trial : rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection-a randomized controlled study
- Thrombopoietin Stimulates Murine Lineage Negative, Scal-1^+, C-Kit^+, CD34^- Cells: Comparative Study With Stem Cell Factor or Interleukin-3
- The Decrease in Average Years of Life Lost Due to Breast Cancer in Japan during the Period from 1995 to 2006
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
- 58. Health care system in Vietnam : current situation and challenges
- Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease : the Ohasama study
- Inhibitory Effect of AL-3264, a New Antiallergic Agent, on the Prausnitz-Kustner Reaction and Leukotriene Production in Monkeys
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Impact of Smoking and Other Lifestyle Factors on Life Expectancy among Japanese : Findings from the Japan Collaborative Cohort (JACC) Study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- HLA-A Alleles and the Risk of Cervical Squamous Cell Carcinoma in Japanese Women